Morning Industry Symposium:
DCISionRT: Personalising treatment for women with DCIS

Supported by GenesisCare / PreludeDX


Friday, October 14, 2022                                                                                                                                                                     Hall B (Great Hall 2)
Breakfast will be served from 07:00-07:30, half an hour prior to the start of the session.
Admission to this symposium is included as part of the congress registration.

Chairperson: Marcus Dreosti, Adelaide, Australia
Delivering precision medicine to women with DCIS in Australia: Clinical application and how it has changed the management of women with DCIS
Bruce Mann, Melbourne, Australia
Science and clinical evidence: Consistent predictor of radiation therapy benefit
Troy Bremer, Laguna Hills, CA, USA
Future advances in DCISionRT testing
Frank A. Vicini, Royal Oak, MI, USA
Interim analysis of the PREDICT Registry Australia: Impact on treatment recommendations
Yvonne Zissiadis, Perth, Australia
Skip to content